Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris
NCT00287547 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 144
Last updated 2011-04-25
Summary
The purpose of this study is to assess the safety, pharmacokinetics and clinical activity and immunogenicity of BMS-188667 (CTLA4Ig) in subjects with psoriasis vulgaris
Conditions
- Psoriasis Vulgaris
Interventions
- DRUG
-
CTLA4Ig / Abatacept
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-03-31
- Primary Completion
- 1998-01-31
- Completion
- 1998-01-31
Countries
- United States
Study Locations
More Related Trials
-
Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis
NCT02534636 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis
NCT02763969 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis
NCT00399906 ·Status: COMPLETED ·Phase: PHASE2
-
Study of BMS-587101 in Patients With Moderate to Severe Psoriasis
NCT00162253 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis
NCT02852967 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
NCT03611751 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00570986 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00292396 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis
NCT00534313 ·Status: TERMINATED ·Phase: PHASE2
-
A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT03410992 ·Status: COMPLETED ·Phase: PHASE3
-
Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis
NCT00805480 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003)
NCT01225731 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque Psoriasis
NCT05645627 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis
NCT00106847 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis
NCT04603027 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
NCT01154101 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis
NCT00669916 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis
NCT00770965 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp
NCT00669214 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants
NCT04316585 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00235820 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 4 Clinical Study of Brodalumab
NCT04183881 ·Status: COMPLETED ·Phase: PHASE4
-
An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis
NCT03924427 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.
NCT02425826 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis
NCT06875934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2